A Prospective, Randomized, Clinical Study on the Effects of CPP-ACP-paste, Fluoride and a Combination on the Evolution of White Spot Lesions in Orthodontic Patients After Debonding.

NCT05710874 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 107

Last updated 2023-08-24

No results posted yet for this study

Summary

The goal of this randomized clinical trial is to compare the influence of casein phosphopeptide amorphous calcium phosphate (CPP-ACP), CPP-ACP in combination with fluoride (CPP-ACPF), high fluoride concentration, and conventional fluoride toothpaste on the color and size of white spot lesions (WSLs) in orthodontic patients following bracket removal.

Conditions

  • White Spot Lesion
  • Orthodontic Appliance Complication

Interventions

OTHER

CPP-ACP paste

Daily application of CPP-ACP (Casein phosphopeptide amorphous calcium phosphate) paste (Tooth Mousse®) in addition to twice daily use of conventional toothpaste.

OTHER

CPP-ACPF paste

Daily application of CPP-ACPF (Casein phosphopeptide amorphous calcium phosphate in combination with fluoridepaste) (MI Paste Plus®) in addition to twice daily use of conventional toothpaste.

OTHER

1.25% fluoride gel

Weekly application of 1.25% fluoride gel (Elmex Medical Gel®) in addition to twice daily use of conventional toothpaste.

OTHER

Conventional

Twice daily use of conventional toothpaste.

Sponsors & Collaborators

  • University Hospital, Ghent

    lead OTHER

Principal Investigators

  • Levine Gavel · Postgraduate Orthodontics

  • Valentina Elena Arevalo Cabrera · Master Student Oral Health Sciences

  • Deseyne Thomas · Alumnus Orthodontics

  • Guy AM De Pauw · Professor dr. in Orthodontics

  • Noëmi MC De Roo · Doctorate in Orthodontics

  • Liesbeth Temmerman · dr. in Orthodontics

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
12 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-09-23
Primary Completion
2023-03-29
Completion
2023-03-29

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05710874 on ClinicalTrials.gov